STOCK TITAN

Cellectar Biosciences: Balyasny reports ~9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cellectar Biosciences, Inc. (CLRB) is the issuer in an amended beneficial-ownership report by Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny. Each reporting person may be deemed to beneficially own 944,265 shares, or approximately 9.99%; this is the same reported position attributed to each, not five separate positions.

The reported amount consists of 220,000 common shares and 724,265 shares issuable upon exercise of 1,289,432 warrants. The warrants are subject to a Beneficial Ownership Limitation that prevents exercise to the extent it would result in ownership above 9.99%. The ownership calculation references 9,452,108 shares outstanding as of August 11, 2026. Atlas Private Holdings (Cayman) Ltd. is identified as the direct holder of 220,000 common shares and as entitled to dividends and proceeds from sales of the reported securities; it is an investment-management client of Balyasny Asset Management L.P.

Beneficially owned shares 944,265 shares The same reported position is attributed to each of the five reporting persons.
Beneficial ownership percentage Approximately 9.99% Reported for each reporting person; the warrants are subject to the ownership limitation.
Common shares directly held 220,000 shares Atlas Private Holdings (Cayman) Ltd. is identified as the direct holder.
Shares issuable upon warrant exercise 724,265 shares Included in the reported beneficial-ownership amount.
Warrants 1,289,432 warrants Subject to the Beneficial Ownership Limitation.
Shares outstanding 9,452,108 shares As of August 11, 2026.
Beneficial Ownership Limitation regulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
beneficially own regulatory
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole voting power regulatory
"has the sole power to vote or to direct the vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"has the sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLRB shares did the Balyasny reporting persons report owning?

Each of the five reporting persons may be deemed to beneficially own 944,265 shares, approximately 9.99% of the class; this is the same attributed position, not five separate holdings. It comprises 220,000 common shares and 724,265 shares issuable upon warrant exercise.

How does the CLRB warrant ownership limit work?

The warrants may not be exercised to the extent that exercise would cause the holder to beneficially own more than 9.99% of the shares outstanding. The ownership calculation references 9,452,108 shares outstanding as of August 11, 2026.

Who receives dividends and sale proceeds from the CLRB securities in the report?

Atlas Private Holdings (Cayman) Ltd. has the right to receive dividends from, and proceeds from the sale of, the reported securities. It is an investment-management client of Balyasny Asset Management L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





15117F880

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading